CFPAC-1（胰腺癌細(xì)胞） 
產(chǎn)品品牌：ATCC
價(jià)格：詢價(jià)
我公司擁有國(guó)內(nèi)的細(xì)胞服務(wù)技術(shù)、先進(jìn)的儀器設(shè)備和專業(yè)的ELISA檢測(cè)試劑盒， 生物素標(biāo)記、熒光素標(biāo)記、酶標(biāo)記等，廣泛用于多種分析研究與技術(shù)測(cè)定。CFPAC-1（胰腺癌細(xì)胞） 
 

產(chǎn)品說明：
Sundstrom C and Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line （U-937）. Int. J. Cancer 17:565-577, 1976 PubMed: 76189427 Ralph P , et al. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J. Exp. Med. 143: 1528-1533, 1976. PubMed: 1083890 Gene expression during normal and malignant differentiation. 143: London: Academic Press; 1985, pp. 57-72. International symposium on new trends in human immunology and cancer immunotherapy. Paris: Doin Editeurs; 1980, pp. 271-292. Koren HS , et al. In vitro activation of a human macrophage-like cell line. Nature 279: 328-331, 1979. PubMed: 450085 Gidlund M , et al. Natural killer cells kill tumour cells at a given stage of differentiation. Nature 292: 848-850, 1981. PubMed: 7266653 Olsson I , et al. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res. 43: 5862-5867, 1983
相關(guān)產(chǎn)品：
 
A3（淋巴細(xì)胞白血病細(xì)胞） 
PANC-1（胰腺癌細(xì)胞） 
Jurkat,Clone E6-1（T 淋巴細(xì)胞白血病細(xì)胞） 
SK-HEP-1（肝癌細(xì)胞） 
HL-60（急性粒細(xì)胞白血病細(xì)胞） 
HCCLM3（肝癌細(xì)胞） 
TT（人甲狀腺癌細(xì)胞）